Presacral Myelolipoma  by Liu, Yung-Liang et al.
Myelolipomas are benign tumors that are mainly com-
posed of fatty tissue interspersed with extramedullary
hematopoietic elements [1]. Myelolipomas are most
often found in the adrenal gland but may rarely occur
in extra-adrenal locations. Previous reports of extra-
adrenal myelolipomas revealed that more than half 
of these cases occurred in the presacral region [2]. Like
most retroperitoneal tumors, symptoms do not develop
until effects related to the mass occur. In this article,
we discuss the pathology, morphologic differential diag-
nosis, and appropriate management of extra-adrenal
myelolipoma to bring this condition to the attention
of gynecologists.
A 65-year-old, gravida 2, para 2, postmenopausal
woman complained of recent onset of lower abdomi-
nal fullness, swelling of her left leg, and constipation
that had worsened over the past 2 months. Her med-
ical history included coronary artery disease with an
old myocardial infarction, arrhythmia, mild cirrhosis of
the liver, transabdominal hysterectomy, appendectomy,
and laminectomy of L5 because of spinal changes from
tuberculosis. On physical examination, her blood pres-
sure was 121/78 mmHg, heart rate was 80/minute,
respiration rate was 18/minute, and temperature was
36.6°C. Her heart rate and lung sounds were normal,
and abdominal examination showed moderate abdom-
inal distension and a 12-cm longitudinal surgical scar
over the abdomen. Her abdomen was otherwise soft,
with mild tenderness in her lower quadrant without rigid-
ity or palpable masses. Digital examination showed no
tenderness or fullness. The left lower leg had mild edema.
Abnormal laboratory data included the following:
hemoglobin, 11.4 g/dL; sodium, 133 mmol/L; potas-
sium, 3.0 mmol/L; aspartate transaminase, 40 U/L;
albumin, 2.1 g/dL; and CA125, 377 U/mL. A chest film
revealed pleural effusion of the bilateral costophrenic
angle and patchy opacity of the left lower lung zone.
An electrocardiogram showed an old infarction of the
anterior wall. Ultrasonography of the pelvis revealed a
large, heterogeneous, predominantly hyperechoic mass.
Non-contrast and contrast-enhanced computed tomog-
raphy (CT) of the abdomen and pelvis showed a pre-
sacral 11.5 × 8.5 × 5 cm mass with fatty and soft-tissue
components (Figure 1). Other findings included mild
hydronephrosis of both kidneys, irregular contour with
hypertrophic change of the left lobe of the liver (favoring
cirrhosis), small cysts in the left kidney, bilateral pleu-
ral effusion, and a small amount of ascites. The mass
appeared to be adherent to the sacrum, encircling the
rectum and causing mild hydronephrosis of both kidneys.
An exploratory laparotomy disclosed a large retro-
peritoneal tumor between the rectum and sacrum in
the true pelvis (Figure 2). The tumor consisted of soft,
greasy, yellow tissue. During removal of the tumor, sig-
nificant bleeding was noted from the presacral region.
Blood transfusions were required. Frozen section showed
no evidence of malignancy.
The histopathologic study showed predominantly
mature adipose tissue intermixed with extramedullary
hematopoietic components. This was consistent with
myelolipoma (Figure 3). No evidence of malignancy was
seen. The tumor was 12 × 9 × 5 cm in size and weighed
405 g. The patient’s leg edema subsided postoperatively.
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Figure 1. Pelvic contrast-enhanced computed tomography
shows a well-circumscribed, presacral, soft-tissue mass. The
arrow indicates the tumor.
Myelolipomas are benign tumors composed of
mature fatty tissue interspersed with hematopoietic
tissue. The adrenal gland is the most common site, but
myelolipomas also occur rarely in extra-adrenal loca-
tions. The etiology is still obscure. Some reports pro-
posed that endocrine dysfunction be included in the
etiology of adrenal and extra-adrenal myelolipoma [3].
Clinical examples like Cushing’s syndrome, Addison’s
disease, adrenal hyperplasia, and chronic use of exoge-
nous steroids have been associated with myelolipoma
[3–5]. Experimental evidence like injecting pituitary ex-
tract subcutaneously into rats to induce myelopoiesis
has been reported [3,6].
Singla et al [2] summarized 37 reported cases of
extra-adrenal myelolipomas. Eight patients had a history
of diabetes mellitus (21.6%), seven had a past history
of cancer (18.9%), and six had a past history of steroid
use (16.2%). The mean age of patients found to have
this tumor was 65.2±11.2 years, and the male-to-female
ratio was 13:24 (i.e. 0.54). These tumors were most
commonly found in the presacral region (n =15; 40.5%),
followed by the retroperitoneal (n = 8; 21.6%), thoracic
(n = 5; 13.5%), pelvic (n = 3; 8.1%), renal (n = 2; 5.4%),
gastric (n = 1; 2.7%), hepatic (n = 1; 2.7%), perivesicular
(n = 1; 2.7%) and multifocal (n = 1; 2.7%) regions [2].
Our patient’s tumor occurred in the most common site,
the presacral region. Her presenting symptoms were
related to the effects of the mass.
It is important to distinguish presacral myelolipomas
from retroperitoneal tumors, which are more common
and aggressive neoplasms. In a 1989 study, Pinson et al
[7] divided retroperitoneal tumors into six categories:
(1) benign, (2) germ cell, (3) lymphoma, (4) sarcoma,
(5) carcinomas, and (6) undifferentiated malignancy.
Of these tumors, 89% were malignant [3,7]. This figure
is supported by several other studies [8].
For pelvic tumor, ultrasonography, CT scans (partic-
ularly spiral CT scans) and magnetic resonance imag-
ing can provide much information about the location,
consistency, extent, and possible origin of the mass.
Needle biopsy can be useful in determining which ther-
apeutic options could be considered. However, it is often
difficult to label a retroperitoneal neoplasm as benign
based on needle biopsy or radiographic findings, because
both benign and malignant tumors can share similar
characteristics [3].
Surgery is the preferred treatment for most primary
retroperitoneal tumors. In this patient, even though there
was no preoperative histologic diagnosis, frozen section
played an important role in determining the extent of
surgery needed. Because there was no evidence of malig-
nancy, extensive resection was avoided (34% of ret-
roperitoneal sarcomas require resection of adjuvant
organs) [3,9]. This further decreased the possibility of
surgical complications, such as easy bleeding, when the
sacral attachments are resected [2].
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Figure 2. (A) A large retroperitoneal tumor (arrow) located between the rectum and sacrum is seen in the true pelvis. (B) The
mass contains red friable tissue and yellow adipose tissue.
Figure 3. Histopathology of the tumor shows mature adipose
tissue intermixed with normal hematopoietic cells (hematoxylin
and eosin, 400×).
In conclusion, extra-adrenal myelolipomas are rare
benign tumors. Due to their fatty and soft-tissue com-
ponents, it is not easy to distinguish them from other
malignancies, like liposarcoma, from radiographic find-
ings [3]. Diagnostic procedures, like CT-guided percu-
taneous fine-needle aspiration biopsy or frozen section,
might be useful in the diagnosis [10–12]. We report this
case to help gynecologists become aware of the possi-
bility of extra-adrenal myelolipoma when they formulate
a differential diagnosis for retroperitoneal tumors.
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